¶¾¦w±¶´£¿ô¡A¦bÂå¾Ç´Á¥Z¬ã¨s¤¤µo²{¡A¨ÅÀù±wªÌ¨C4¤H´N¦³1¤H¡A¦bªvÀø5¦Ü10¦~«áµo¥Í´_µo©ÎÂಾ
[v]¡C¥@¬É¥~¬ì¸~½F´Á¥Z¬ã¨s¤¤¤]´£¨ì¡A¹L¥b¼Æ²üº¸»X¶§©Ê¡þHER2³±©Ê¨ÅÀù±wªÌ¡A¶EÂ_5¦~«á¥i¯àÂಾ´_µo
[vi] ¡CY±wªÌ±a¦³¯S®í°ò¦]¬ðÅÜ¡A¬ã¨sÅã¥Ü¨ã¦³¸û°ªªº´_µo²v¥B§ó®e©ö²£¥Í§ÜÃÄ©Ê¡A¨ÏªvÀø®ÄªG¤£¨Î
[vii] ¡C
¦o©IÆ~¡A°ò¦]ÀË´ú¬OÀù¯gªvÀø¥²n¹Lµ{¡A¯à¨ó§U°Ï¤ÀÀù¯g¤£¦P¨È«¬¡A§ä¥X³Ì¾A·íªºªvÀø¤è¦¡¡A¤]¦³§U©óµû¦ôªvÀø«áª¬ªp¡C¤×¨ä²üº¸»X¶§©Ê/HER2³±©Ê¯f±w¦³°ª´_µo·ÀI¡AªvÀø«á¥²¶·«ö·ÓÂå¥Í«ü¥Ü©w´ÁÀˬd¡A´Nºâ¥X²{Âಾ´_µo©Î§ÜÃÄ©Ê¡A¤]À³¶X¦¤¶¤J±±¨îÀù²ÓM¡AÅý±wªÌÄ~Äò³¦ñ³Ì·R®a¤H»P§¹¦¨¹Ú·Q¡C
¬°¤F¨¾ªv¨ÅÀù¡A½Ã¥ÍºÖ§Q³¡°ê¥Á°·±d¸p´£¨Ñ45·³¦Ü¥¼º¡70·³¤k©Ê¡A¨C2¦~1¦¸¨Å©Ð¿zÀË¡A¦pªG¦³®a±Ú¥v¡A¯à°÷´£«e¦Ü40·³¶}©l¡C¶V¦ªvÀøÀù²ÓM«Â¯Ù¶V¤p¡AªvÀø¦¨ªG¤]¶V¦n¡C¤k¬PLulu¡]¶À¸ô±ê¯ô¡^¥X®u¬Û®¼¨ÅÀù¯f¤Í¡A¥xÆW¦~»´¯f¤Í¨ó·|©M¨ÅÀùªÀ¹Î¡uªáºy¤k«ÄGOGOGO¡v¤]©IÆ~±¹ï¯e¯f¤£»´©ö©ñ±ó¡A¿n·¥ªvÀø¡B©w´Á°lÂÜ¡AÂਫá¨ÌµM¯à«ùÄò°{Ä£ªáºy¤H¥Í¡C
[i] ½Ã¥ÍºÖ§Q³¡°ê¥Á°·±d¸p109¦~Àù¯gµn°O³ø§i¡G
https://www.hpa.gov.tw/File/Attach/16434/File_21196.pdf
[ii] ½Ã¥ÍºÖ§Q³¡°ê¥Á°·±d¸p109¦~Àù¯gµn°O³ø§i¡G
https://www.hpa.gov.tw/File/Attach/16434/File_21196.pdf
[iii] NCCN guid line: National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) ¡V Breast Cancer. Version 4.2023.
[iv]°ê»ÚªvÀøµû¤ñ:
ESMO-MCBS for Solid Tumours | ESMO
[v]°±¤î¤º¤ÀªcªvÀø 5 ¦~«á20 ¦~´Á¶¡¨ÅÀù´_µoªº·ÀI
https://pubmed.ncbi.nlm.nih.gov/29117498/
[vi] ¥i¤â³N¨Å¸¢Àùªì©lªvÀø5 ¦~«á´_µo¦]¯À¹w´ú
https://pubmed.ncbi.nlm.nih.gov/27557635/
[vii] Outcome and molecular landscape of patients with PIK3CA-mutatedmetastatic breast cancer-Available online 24 January 2020
¥»¤å¸g °·±dÂåÀøºô ±ÂÅv¥Zµn¡Aì¤åµoªí
©ó¦¹
¡i°·±dÂåÀøºô¡þ°OªÌ¾G©yªâ³ø¾É¡j2023/10/06